⌘K

Home/Filings/4/0001104659-20-140310

4//SEC Filing

GRINT PAUL C 4

Accession 0001104659-20-140310

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 9:53 PM ET

Size

5.1 KB

Accession

0001104659-20-140310

Insider Transaction Report

Form 4

Period: 2020-12-22

Inhibikase Therapeutics, Inc.IKT

Director

Transactions

Award
Stock Option (right to buy)
2020-12-22+6,825→ 6,825 total
Exercise: $10.00From: 2021-12-22Exp: 2030-12-22→ Common Stock (6,825 underlying)

Documents

1 file

4
tm2039455d4_form4.xmlPrimary
FORM 4

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0001236548

Filing Metadata

Form type: 4
Filed: Dec 28, 7:00 PM ET
Accepted: Dec 29, 9:53 PM ET
Size: 5.1 KB

View on SEC.gov